Authors


Kenneth Getz, MBA

Latest:

ROI and Rare Disease: Retooling the ‘Gene’ Value Machine

Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.


Jimmy Black

Latest:

Spanning the Treatment Gap

How a diabetes field team helped docs overcome the treatment gap


Dee Lee

Latest:

Put the freeze on credit card debt

Avoid high interest and dig out of debt.


Paul LeBon

Latest:

Boost your productivity with voicemail

Simple messages can be tremendous tools fo success.


Rachael Zuckerman

Latest:

Make a Match

Big Pharma is finally making a commitment to partner-based outsourcing.


Simon Estcourt, IDIS

Latest:

Boundaries of Expanded Access

More patients are demanding drugs--and showing up everywhere form YouTube to the Supreme Court. But to offer access to investigational drugs, companies first need to know the rules


Mike Turcotte

Latest:

Reimbursement: The foundation for financial decisions

In our quest as sales reps to provide our physician customers with a valuable sales call, it is crucial to understand what the driving forces are in healthcare delivery and how they affect these customers.


Peter Carlin

Latest:

The Battle for Oncology KOLs

Companies are fighting for strong relationships with key opinion leaders-and Genentech is winning, hands down.


Anthony Bianciella

Latest:

Ready, Aim, Sell

Technology isn't the magic bullet, but it can help you hit your target


Linda Meyerson

Latest:

Rethinking the Sponsor-Investigator Relationship

When it comes to working with clinical research sites, pharmaceutical companies should take a page out of the automakers' playbook


Margaret-Ann Cole

Latest:

Putting the "I" in "Team"

Pharma is embracing the cross-functional team. But that doesn't mean that you must blend in with the sheep. Putting your best foot forward strengthens the team...and you.


Alan Klein

Latest:

Wyeth V. Levine: An Attorneys' Perspective

Lawyers from Duane Morris LLP offer their take on the Supreme Court's groundshaking preemption decision


Robert Bedford, InfoMedics

Latest:

Tough Nut to Crack

An innovative approach bridges the pediatric communication gap


Ronald Branning

Latest:

Detailing Gets Personal

As pharma sales forces grow and their productivity declines, the question on everyone's mind is, "Has the traditional detail lost its punch?" The answer is unequivocally no. The sales force is still the best medium for forging valued and trusted relationships with targeted physicians.


Richard V. Michaels

Latest:

Mentoring for performance improvement in the workplace

The traditional boss-employee relationship has been replaced by a model in which the partnerships between managers and their employees - as well as those among managers across the organization - are a vital tool for enhancing performance.


Barbara Schreiner

Latest:

Spanning the Treatment Gap

How a diabetes field team helped docs overcome the treatment gap


Thomas Nagle

Latest:

Money-Back Guarantee

...and other ways you never thought to sell your drugs